DULCOLAX- bisacodyl suppository États-Unis - anglais - NLM (National Library of Medicine)

dulcolax- bisacodyl suppository

boehringer ingelheim pharmaceuticals, inc. - bisacodyl (unii: 10x0709y6i) (deacetylbisacodyl - unii:r09078e41y) - drug facts use - for temporary relief of occasional constipation and irregularity - this product generally produces bowel movement in 15 minutes to 1 hour warnings for rectal use only ask a doctor before use if you have - stomach pain, nausea or vomiting - a sudden change in bowel habits that lasts more than 2 weeks when using this product it may cause stomach discomfort, faintness, rectal burning and mild cramps stop use and ask a doctor if - you have rectal bleeding or no bowel movement after using this product. these could be signs of a serious condition. - you need to use a laxative for more than 1 week if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away. directions other information - store at 20°-25°c (68°-77°f) inactive ingredient hard fat questions? call 1-888-285-9159 (english/spanish), m – f, 8:30 – 5 est, or visit www.dulcolax.com distributed by: boehringer ingelheim

DULCOLAX PICO LIQUID 5 MG/5ml Oral Solution Irlande - anglais - HPRA (Health Products Regulatory Authority)

dulcolax pico liquid 5 mg/5ml oral solution

boehringer ingelheim limited - sodium picosulphate monohydrate - oral solution - 5 mg/5ml - contact laxatives

DULCOLAX SUPPOSITORY 10 mg Singapour - anglais - HSA (Health Sciences Authority)

dulcolax suppository 10 mg

opella healthcare singapore pte. ltd. - bisacodyl - suppository - 10 mg - bisacodyl 10 mg

Dulcolax Pico Liquid 5mg/ml oral solution Malte - anglais - Medicines Authority

dulcolax pico liquid 5mg/ml oral solution

boehringer ingelheim limited - sodium picosulfate 5 mg/5ml - oral solution

Dulcolax Pico Liquid 5 mg/5 ml, oral solution Irlande - anglais - HPRA (Health Products Regulatory Authority)

dulcolax pico liquid 5 mg/5 ml, oral solution

sanofi-aventis ireland limited t/a sanofi - sodium picosulfate - oral solution - 5 mg/5ml - contact laxatives; sodium picosulfate

DULCOLAX bisacodyl 5 mg tablet blister pack Australie - anglais - Department of Health (Therapeutic Goods Administration)

dulcolax bisacodyl 5 mg tablet blister pack

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bisacodyl, quantity: 5 mg - tablet, enteric coated - excipient ingredients: magnesium stearate; soluble maize starch; macrogol 6000; sucrose; white beeswax; lactose monohydrate; shellac; acacia; glycerol; methacrylic acid copolymer; carnauba wax; titanium dioxide; purified talc; maize starch; purified water; castor oil; iron oxide yellow - for the treatment of constipation. under medical supervision, dulcolax can be used for the evacuation of the bowel before a radiological examination or as an enema alternative.